Evonik Industries AG is a Germany-based specialty chemicals company. The Company engages in the development, construction, distribution and trade of scientific equipment, chemicals and accessories for use in the fields of life sciences and biotechnology..
| Price and Volume | |
|---|---|
| Volume | |
| Ten Day Average Volume | 738.5K |
| Three Month Average Volume | 20.9M |
| High Low | |
| Fifty-Two Week High | 20.96 EUR |
| Fifty-Two Week Low | 15.79 EUR |
| Fifty-Two Week High Date | 15 May 2024 |
| Fifty-Two Week Low Date | 26 Oct 2023 |
| Price and Volume | |
| Current Price | 20.1 EUR |
| Beta | 1 |
| Relative Price Change | |
| Four Week Relative Price Change | -0.89% |
| Thirteen Week Relative Price Change | -0.92% |
| Twenty-Six Week Relative Price Change | 9.43% |
| Fifty-Two Week Relative Price Change | -5.25% |
| Year-to-Date Relative Price Change | -3.86% |
| Price Change | |
| One Day Price Change | 0.25% |
| Thirteen Week Price Change | 0.80% |
| Twenty-Six Week Price Change | 16.93% |
| Five Day Price Change | 2.34% |
| Fifty-Two Week Price Change | 13.24% |
| Year-to-Date Price Change | 8.65% |
| Month-to-Date Price Change | 0.25% |
| Per Share Data | |
|---|---|
| Book Value | |
| Book Value Per Share (Last Fiscal Year) | 19.12017 EUR |
| Book Value Per Share (Most Recent Quarter) | 19.0279 EUR |
| Tangible Book Value Per Share (Last Fiscal Year) | 7.26395 EUR |
| Tangible Book Value Per Share (Most Recent Quarter) | 7.11373 EUR |
| EBITD | |
| EBITD Per Share (Trailing Twelve Months) | 8.09958 EUR |
| Revenue | |
| Revenue Per Share (Last Fiscal Year) | 32.7618 EUR |
| Revenue Per Share (Trailing Twelve Months) | 32.02091 EUR |
| Dividend | |
| Dividend Per Share (Last Fiscal Year) | 1.17 EUR |
| Dividend Per Share (Trailing Twelve Months) | 1.17 EUR |
| Dividend Per Share (5 Year) | 1.162 EUR |
| Earnings Per Share | |
| Excluding Extraordinary Items (Last Fiscal Year) | -0.99785 EUR |
| Excluding Extraordinary Items (Trailing Twelve Months) | -0.20972 EUR |
| Normalized (Last Fiscal Year) | 0.2618 EUR |
| Basic Excluding Extraordinary Items (Last Fiscal Year) | -0.99785 EUR |
| Basic Excluding Extraordinary Items (Trailing Twelve Months) | -0.20972 EUR |
| Including Extraordinary Items (Last Fiscal Year) | -0.99785 EUR |
| Including Extraordinary Items (Trailing Twelve Months) | -0.20972 EUR |
| Cash | |
| Cash Per Share (Last Fiscal Year) | 2.42489 EUR |
| Cash Per Share (Most Recent Quarter) | 1.85193 EUR |
| Cash Flow Per Share (Last Fiscal Year) | 1.38627 EUR |
| Cash Flow Per Share (Trailing Twelve Months) | 2.74792 EUR |
| Free Cash Flow Per Share (Trailing Twelve Months) | 2.81577 EUR |
| Margins | |
|---|---|
| Cash Flow Revenue | |
| Cash Flow Revenue (5 Year) | 1 |
| Cash Flow Revenue (Trailing Twelve Months) | 9 |
| Pretax Margin | |
| Pretax Margin (Trailing Twelve Months) | 0.97% |
| Pretax Margin (Last Fiscal Year) | -2.30% |
| Pretax Margin (5 Year) | 4.45% |
| Gross Margin | |
| Gross Margin (Last Fiscal Year) | 22.21% |
| Gross Margin (Trailing Twelve Months) | 27.02% |
| Gross Margin (5 Year) | 25.47% |
| Operating Margin | |
| Operating Margin (Last Fiscal Year) | -1.59% |
| Operating Margin (Trailing Twelve Months) | 1.81% |
| Operating Margin (5 Year) | 5.10% |
| Net Profit Margin | |
| Net Profit Margin (Last Fiscal Year) | -2.96% |
| Net Profit Margin (Trailing Twelve Months) | -0.49% |
| Net Profit Margin (5 Year) | 2.90% |
| Growth | |
|---|---|
| Book Value | |
| Book Value Per Share (5 Year) | 2.88% |
| Tangible Book Value (5 Year) | 16.24% |
| Free Operating Cash Flow | |
| Free Operating Cash Flow (5 Year) | -1.49% |
| Revenue | |
| Revenue Change MRQ vs 1 Year Ago | 1.13% |
| Revenue Growth (3 Year) | 2.85% |
| Revenue Change (Trailing Twelve Months) | -11.73% |
| Revenue Per Share Growth | 2.85% |
| Revenue Growth (5 Year) | 7.76% |
| Capital Spending Debt | |
| Capital Spending (5 Year) | -3.51% |
| Total Debt (5 Year) | 1.91% |
| Dividends | |
| Dividend Growth (3 Year) | 0.58% |
| Earnings Per Share | |
| EPS Change MRQ vs 1 Year Ago | 98.28% |
| EPS Change (Trailing Twelve Months) | 66.70% |
| EPS Growth (3 Year) | -99,999.99% |
| EPS Growth (5 Year) | -99,999.99% |
| EBITDA | |
| EBITDA (5 Year) | -7.31% |
| EBITDA (5 Year Interim) | 12.28% |
| Net Profit Margin | |
| Net Profit Margin Growth (5 Year) | -99,999.99% |
| Valuation | |
|---|---|
| Total Price to Book | |
| Price to Tangible Book (Last Fiscal Year) | 3 |
| Price to Tangible Book (Most Recent Quarter) | 3 |
| Price to Free Cash Flow | |
| Price to Free Cash Per Share (Last Fiscal Year) | 37 |
| Price to Free Cash Per Share (Trailing Twelve Months) | 7 |
| Net Debt | |
| Net Debt (Most Recent Quarter) | 3.8B |
| Net Debt (Last Fiscal Year) | 3.1B |
| Price to Sales | |
| Price to Sales (Last Fiscal Year) | 1 |
| Price to Sales (Trailing Twelve Months) | 1 |
| Price to Earnings | |
| PE Excluding Extraordinary Items (Last Fiscal Year) | -100,000 |
| PE Normalized (Last Fiscal Year) | 77 |
| PE Basic Excluding Extraordinary Items (Trailing Twelve Months) | -100,000 |
| PE Excluding Extraordinary Items High (Trailing Twelve Months) | 33 |
| PE Excluding Extraordinary Items Low (Trailing Twelve Months) | 9 |
| PE Including Extraordinary Items (Trailing Twelve Months) | -100,000 |
| Dividends | |
| Dividend Yield (5 Year) | 4.89% |
| Dividend Yield | 5.82% |
| Current Dividend Yield | 5.82% |
| Price to Book | |
| Price to Book (Last Fiscal Year) | 1 |
| Price to Book (Most Recent Quarter) | 1 |
| Financial Strength | |
|---|---|
| Debt to Equity | |
| Long Term Debt to Equity (Last Fiscal Year) | 37 |
| Long Term Debt to Equity (Most Recent Quarter) | 39 |
| Payout Ratio | |
| Payout Ratio (Last Fiscal Year) | -99,999.99% |
| Payout Ratio (Trailing Twelve Months) | -99,999.99% |
| Quick Ratio | |
| Quick Ratio (Last Fiscal Year) | 1 |
| Quick Ratio (Most Recent Quarter) | 1 |
| Enterprise Value | |
| Current Enterprise Value to Free Cash Flow (Last Fiscal Year) | -100,000 |
| Current Enterprise Value to Free Cash Flow (Trailing Twelve Months) | 24 |
| Current Ratio | |
| Current Ratio (Last Fiscal Year) | 1 |
| Current Ratio (Most Recent Quarter) | 1 |
| Free Cash Flow | |
| Free Cash Flow (Last Fiscal Year) | 256.0M |
| Free Cash Flow (Trailing Twelve Months) | 1.3B |
| Net Interest Coverage | |
| Net Interest Coverage (Last Fiscal Year) | 4 |
| Net Interest Coverage (Trailing Twelve Months) | 9 |
| Total Debt to Equity | |
| Total Debt to Equity (Last Fiscal Year) | 48 |
| Total Debt to Equity (Most Recent Quarter) | 53 |
| Management Effectiveness | |
|---|---|
| Return on Assets | |
| Return on Assets (Last Fiscal Year) | -2.17% |
| Return on Assets (Trailing Twelve Months) | -0.36% |
| Return on Assets (5 Year) | 2.01% |
| Return on Equity | |
| Return on Equity (Last Fiscal Year) | -4.68% |
| Return on Equity (Trailing Twelve Months) | -0.98% |
| Return on Equity (5 Year) | 4.53% |
| Return on Investment | |
| Return on Investment (Last Fiscal Year) | -2.67% |
| Return on Investment (Trailing Twelve Months) | -0.45% |
| Return on Investment (5 Year) | 2.42% |